Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 11, 2021 Filed Mar 16, 2021 00:26 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,000 $26.49 $185,430.00
Disclosure

SEC source: 0001567619-21-006359 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

Read SEC document
March 05, 2021 Filed Mar 9, 2021 22:59 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-005934 · doc1.xml · derivative · entry 3

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 05, 2021 Filed Mar 9, 2021 22:59 UTC SaleCommon Stock 5,000 $76.28 $381,400.00
Disclosure

SEC source: 0001567619-21-005934 · doc1.xml · nonDerivative · entry 2

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,840

Read SEC document
March 05, 2021 Filed Mar 9, 2021 22:59 UTC Exercise / conversionCommon Stock 5,000 $26.49 $132,450.00
Disclosure

SEC source: 0001567619-21-005934 · doc1.xml · nonDerivative · entry 1

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,840

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2021 Filed Mar 16, 2021 00:26 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
OtherCommon Stock 100 $77.94 $7,794.00
Disclosure

SEC source: 0001567619-21-006359 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,652

Read SEC document
February 19, 2021 Filed Feb 23, 2021 01:38 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 7,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-004619 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,513

Underlying: Common Stock · 7,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 01:38 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 7,000 $83.58 $585,060.00
Disclosure

SEC source: 0001567619-21-004619 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,552

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 01:38 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,000 $26.49 $185,430.00
Disclosure

SEC source: 0001567619-21-004619 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 02:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 7,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-004529 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,513

Underlying: Common Stock · 7,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 02:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 7,000 $85.08 $595,560.00
Disclosure

SEC source: 0001567619-21-004529 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,552

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

Read SEC document
February 18, 2021 Filed Feb 20, 2021 02:22 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,000 $26.49 $185,430.00
Disclosure

SEC source: 0001567619-21-004529 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

Read SEC document
February 17, 2021 Filed Feb 19, 2021 02:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 8,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-004473 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,513

Underlying: Common Stock · 8,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 17, 2021 Filed Feb 19, 2021 02:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 8,000 $84.54 $676,320.00
Disclosure

SEC source: 0001567619-21-004473 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,552

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

Read SEC document
February 17, 2021 Filed Feb 19, 2021 02:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 8,000 $26.49 $211,920.00
Disclosure

SEC source: 0001567619-21-004473 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

Read SEC document
February 17, 2021 Filed Feb 19, 2021 22:28 UTC
Ho MaykinDirector
GrantCommon Stock 2,350 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-004525 · doc1.xml · nonDerivative · entry 1

Ho Maykin · CIK 0001646395 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,350

F1 · price: Restricted stock units granted on February 17, 2021 represent a pro rata share of the 2020 annual award for independent directors and vest on the date immediately prior to the date of the Company's next regular annual meeting of stockholders, the same vesting date for the 2020 annual award for all other independent directors.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 23:43 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 7,500 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-004470 · doc1.xml · derivative · entry 3

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 23:43 UTC SaleCommon Stock 7,500 $87.41 $655,575.00
Disclosure

SEC source: 0001567619-21-004470 · doc1.xml · nonDerivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,850

F1 · date: Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 23:43 UTC Exercise / conversionCommon Stock 7,500 $26.49 $198,675.00
Disclosure

SEC source: 0001567619-21-004470 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on January 16, 2020, as amended on August 21, 2020.

Read SEC document
February 03, 2021 Filed Feb 5, 2021 00:48 UTC
Mueller BrianEVP, Chief Financial Officer
Tax withholdingCommon Stock 1,071 $82.82 $88,700.22
Disclosure

SEC source: 0001567619-21-002227 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,673

Read SEC document
January 29, 2021 Filed Feb 2, 2021 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 8,334 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-001901 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,513

Underlying: Common Stock · 8,334 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 8,334 $82.67 $688,971.78
Disclosure

SEC source: 0001567619-21-001901 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,552

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

Read SEC document
January 29, 2021 Filed Feb 2, 2021 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 8,334 $26.49 $220,767.66
Disclosure

SEC source: 0001567619-21-001901 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

Read SEC document
January 28, 2021 Filed Feb 2, 2021 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 8,333 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-001901 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,847

Underlying: Common Stock · 8,333 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 28, 2021 Filed Feb 2, 2021 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 8,333 $82.91 $690,889.03
Disclosure

SEC source: 0001567619-21-001901 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,552

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

Read SEC document
January 28, 2021 Filed Feb 2, 2021 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 8,333 $26.49 $220,741.17
Disclosure

SEC source: 0001567619-21-001901 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

Read SEC document
January 27, 2021 Filed Jan 29, 2021 00:35 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 8,333 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-001679 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,180

Underlying: Common Stock · 8,333 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 27, 2021 Filed Jan 29, 2021 00:35 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 8,333 $85.49 $712,388.17
Disclosure

SEC source: 0001567619-21-001679 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,552

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

Read SEC document
January 27, 2021 Filed Jan 29, 2021 00:35 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 8,333 $26.49 $220,741.17
Disclosure

SEC source: 0001567619-21-001679 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

Read SEC document
December 29, 2020 Filed Dec 31, 2020 01:02 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 1,500 $88.18 $132,270.00
Disclosure

SEC source: 0001567619-20-021724 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,552

F2 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

Read SEC document
December 28, 2020 Filed Dec 31, 2020 01:02 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 1,500 $88.77 $133,155.00
Disclosure

SEC source: 0001567619-20-021724 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,052

F2 · date: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

Read SEC document
October 30, 2020 Filed Feb 12, 2021 02:35 UTC
Acosta AndreaGVP, Chief Accouning Officer
GrantCommon Stock 104 $62.59 $6,508.94
Disclosure

SEC source: 0001567619-21-003206 · doc1.xml · nonDerivative · entry 1

Acosta Andrea · CIK 0001818518 · GVP, Chief Accouning Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,778

F1 · date: Represents shares acquired by the reporting person on October 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
October 30, 2020 Filed Feb 12, 2021 20:10 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 17 $62.59 $1,063.96
Disclosure

SEC source: 0001567619-21-003407 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,761

F1 · date: Represents shares acquired by the reporting person on October 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
October 14, 2020 Filed Oct 15, 2020 23:17 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 2,121 $79.91 $169,489.11
Disclosure

SEC source: 0001567619-20-017890 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,281

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019.

Read SEC document
October 07, 2020 Filed Oct 9, 2020 00:35 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 15,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-20-017700 · doc1.xml · derivative · entry 2

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
October 07, 2020 Filed Oct 9, 2020 00:35 UTC Exercise / conversionCommon Stock 15,000 $26.49 $397,350.00
Disclosure

SEC source: 0001567619-20-017700 · doc1.xml · nonDerivative · entry 1

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,968

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 01:44 UTC PurchaseCommon Stock 900 $78.84 $70,955.37
Disclosure

SEC source: 0001567619-20-016270 · doc1.xml · nonDerivative · entry 2

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,740

F2 · price: The price in column 4 is the weighted average price. The actual purchase price paid ranged from $78.78 to $78.91. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 01:44 UTC PurchaseCommon Stock 11,900 $78.22 $930,759.69
Disclosure

SEC source: 0001567619-20-016270 · doc1.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,840

F1 · price: The price in column 4 is the weighted average price. The actual purchase price paid ranged from $77.78 to $78.76. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 22:56 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,500 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-20-014357 · doc1.xml · derivative · entry 3

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 2,500 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 12, 2020.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 22:56 UTC SaleCommon Stock 2,500 $120.35 $300,875.00
Disclosure

SEC source: 0001567619-20-014357 · doc1.xml · nonDerivative · entry 2

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,840

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 12, 2020.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 22:56 UTC Exercise / conversionCommon Stock 2,500 $26.49 $66,225.00
Disclosure

SEC source: 0001567619-20-014357 · doc1.xml · nonDerivative · entry 1

GREY MICHAEL G · CIK 0001240122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 12, 2020.

Read SEC document
July 20, 2020 Filed Jul 22, 2020 21:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 49,423 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001567619-20-013577 · doc1.xml · derivative · entry 7

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 49,423 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
July 20, 2020 Filed Jul 22, 2020 21:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 75,716 $0.00 Strike: $67.81 $0.00
Disclosure

SEC source: 0001567619-20-013577 · doc1.xml · derivative · entry 6

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75,716 shares

Expires 2023-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
July 20, 2020 Filed Jul 22, 2020 21:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,250 $0.00 Strike: $67.81 $0.00
Disclosure

SEC source: 0001567619-20-013577 · doc1.xml · derivative · entry 5

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,250 shares

Expires 2023-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
July 20, 2020 Filed Jul 22, 2020 21:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 126,389 $130.00 $16,430,570.00
Disclosure

SEC source: 0001567619-20-013577 · doc1.xml · nonDerivative · entry 4

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,995

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $130.00 to $130.04. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
July 20, 2020 Filed Jul 22, 2020 21:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 49,423 $63.10 $3,118,591.30
Disclosure

SEC source: 0001567619-20-013577 · doc1.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,384

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

Read SEC document
July 20, 2020 Filed Jul 22, 2020 21:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 75,716 $67.81 $5,134,301.96
Disclosure

SEC source: 0001567619-20-013577 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

Read SEC document
July 20, 2020 Filed Jul 22, 2020 21:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 1,250 $67.81 $84,762.50
Disclosure

SEC source: 0001567619-20-013577 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

Read SEC document
July 17, 2020 Filed Jul 22, 2020 01:22 UTC
Acosta AndreaGVP, Chief Accouning Officer
Tax withholdingCommon Stock 285 $128.21 $36,539.85
Disclosure

SEC source: 0001567619-20-013554 · doc1.xml · nonDerivative · entry 1

Acosta Andrea · CIK 0001818518 · GVP, Chief Accouning Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,674

Read SEC document
July 13, 2020 Filed Jul 16, 2020 01:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 8,977 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001567619-20-013325 · doc1.xml · derivative · entry 8

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,423

Underlying: Common Stock · 8,977 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
July 13, 2020 Filed Jul 16, 2020 01:32 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 13,810 $0.00 Strike: $67.81 $0.00
Disclosure

SEC source: 0001567619-20-013325 · doc1.xml · derivative · entry 7

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,716

Underlying: Common Stock · 13,810 shares

Expires 2023-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.